amiante et maladies respiratoires
play

Amiante et maladies respiratoires Paul De Vuyst Hopital Erasme ULB, - PowerPoint PPT Presentation

Amiante et maladies respiratoires Paul De Vuyst Hopital Erasme ULB, Bruxelles Asbestos exposure Occupational : salaried or self-standing (independent) workers . Para-occupational : households of asbestos workers (wives, children)


  1. Amiante et maladies respiratoires Paul De Vuyst Hopital Erasme ULB, Bruxelles

  2. Asbestos exposure • Occupational : salaried or self-standing (independent) workers . • Para-occupational : households of asbestos workers (wives, children) • Environmental – naturally occurring asbestos (Turkey, Corsica … ) – neighbourhood of asbestos mines or factories – indoor “passive” exposure in buildings • Mixed environmental and para-occupational

  3. Evolution of occupational exposure • Shift from traditional occupations handling raw asbestos to end-users, especially in the construction industry • Most currently exposed workers are in contact with asbestos material still in place: heating workers, electricians, plumbers, demolition workers, asbestos removers... • These workers are often self-standing workers or even undeclared workers

  4. Asbestos exposure • Occupational : salaried or self-standing workers • Para-occupational : households of asbestos workers (wives, children) • Environmental – Naturally occurring asbestos (Turkey, Corsica … ) – Neighborhood of asbestos mines or factories – Mixed environmental and para-occupational

  5. Asbestos exposure • Occupational : salaried or self-standing workers • Para-occupational : households of asbestos workers (wives, children) • Environmental – Naturally occurring asbestos (Turkey, Corsica … ) – Neighborhood of asbestos mines or factories – Mixed environmental and para-occupational

  6. " Environmental" exposures to tremolite • Domestic use of asbestos deposits (house whitewashing) and farming on contaminated soils • Exposure starts at birth and lasts 24 hour/day • Lung fiber counts indicate cumulative exposures similar to occupational settings Dumortier P et al, Am J Respir Crit Care Med 1998; 158: 1815-1824

  7. Environmental (“imported”) asbestosis • Man, born in Turkey (Malatya) in 1930 • Migrated to Belgium in 1974 (no occupational exposure to asbestos) • BAL – LM : 1530 AB/ml – EM : TREMOLITE 100 %

  8. Asbestos exposure • Occupational : salaried or self-standing workers • Para-occupational : households of asbestos workers (wives, children) • Environmental – Naturally occurring asbestos (Turkey, Corsica … ) – Neighborhood of asbestos mines or factories – Mixed environmental and para-occupational

  9. Asbestos exposure • Occupational : salaried or self-standing workers • Para-occupational : households of asbestos workers (wives, children) • Environmental – Naturally occurring asbestos (Turkey, Corsica … ) – Neighborhood of asbestos mines or factories – Mixed environmental and para-occupational

  10. Respiratory disorders induced by asbestos • Asbestosis (lung fibrosis) • Non-malignant pleural lesions Pleural plaques Diffuse pleural thickening (DPT) Benign asbestos pleural effusion (BAPE) • Malignant Mesothelioma • Lung Cancer

  11. Specific respiratory disorders induced by asbestos • Asbestosis (lung fibrosis) • Non-malignant pleural lesions Pleural plaques Diffuse pleural thickening (DPT) Benign asbestos pleural effusion (BAPE) • Malignant Mesothelioma • Lung Cancer

  12. Specific respiratory disorders induced by asbestos • Asbestosis (lung fibrosis) • Non-malignant pleural lesions Pleural plaques Diffuse pleural thickening (DPT) Benign asbestos pleural effusion (BAPE) • Malignant Mesothelioma • Lung Cancer

  13. Pleural plaques • Most frequent manifestation of asbestos exposure : marker of exposure rather than disease • Circumscribed areas of fibrosis of the parietal pleura, which may calcify • Located on the thoracic wall and on the central parts of the diaphragm • Covered with normal mesothelium, without adherences (normal lung movements) • No detectable effect on lung volumes in individuals, unless very extensive

  14. Specific respiratory disorders induced by asbestos • Asbestosis (lung fibrosis) • Non-malignant pleural lesions Pleural plaques Diffuse pleural thickening (DPT) Benign asbestos pleural effusion (BAPE) • Malignant Mesothelioma • Lung Cancer

  15. Mesothelioma and Asbestos • Amosite and crocidolite have a higher carcinogenic potency than chrysotile: more biopersistent in the lungs • Historical exposures involved generally a mixture of fiber types • The mean latency is at least 40 years since first exposure → the age at onset of exposure is crucial • A threshold of cumulative exposure below which there is no increased risk cannot be defined: low-dose cumulative exposures can cause MM

  16. Black spots on the parietal pleura • Deposition of exogenous inhaled particles is heterogeneous in the parietal pleura and occur in "hot spots" ("black spots") • Present in virtually all urban dwellers • Contain macrophages and lymphocytes • Colour is due to carbonaceous pigments and soot deposits, which indicate the presence of exogenous (inhaled) material

  17. Epidemiology • Background incidence : ± 1/10 6 • Industrialized countries (Europe): 15 - 30/10 6 • Great differences in incidences reported from countries worldwide • Differences mainly due to historical asbestos import and consumption (amounts and types)

  18. Screening • A screening is justified if the early detection of the disease improves the prognosis by more effective medical or surgical treatment and if there are performant screening methods • To date, according to the prevalence, prognosis, available treatments of MPM and to the performance of potential screening methods, the medical efficacy of a large-scale screening is not established

  19. Screening • Low dose CT has not been proven to be an effective screening tool for the detection of (early) MPM • PET and MRI are not available and/or applicable for screening purposes • No evidence that early discovery of MPM will cure the patient or even improve his survival

  20. Belgian study on SMRP and MPF • Soluble Mesothelin Related Peptide • Megakaryocyte Potentiating Factor • « Normal » values or « cut-off » values : 2 nM/ml and 14 mg/ml (specificity 95 % and sensitivity 65 %)

  21. 2 nM/ml 14 mg/ml

  22. Simulation of screening (France) • Mesothelin: Se 80% and Sp 95% • Incidence of MPM: 100 per million (all) exposed subjects • Target population 6 million exposed workers • → 600 expected MPM • True positive cases 480 (600 x 0.8) • False negative cases 120 (600 x 0.2) • False positive cases 300000 (6.10 6 x 0.05) • If test positive: less than 2/1000 « chances » to have mesothelioma (Courtesy of Bruno Housset)

  23. Requirements for recognition (ODF) • Occupational exposure risk confirmed by an occupational enquiry (occupational engineers) • Only for wage-earners (salaried workers). No compensation for self-employed (independent) workers

  24. The Belgian Asbestos Fund (AFA) • Political decision under “social pressure” ( France, ANDEVA and FIVA) • ABEVA (Association belge des victimes de l’amiante) • Cases of mesothelioma and neighbourhood or para- occupational exposures • The Asbestos Fund – Act of December 27th, 2006 – Effective creation on April 1st, 2007 • Organized within the ODF (FMP/FBZ)

  25. Amiante : une “carrière” de 35 ans (1979 – 2014). • Jean Claude Yernault (Pneumologue) • Jacques Jedwab et Pascal Dumortier (Minéralogistes) • Pierre Alain Gevenois (Radiologue) • Myriam Remmelink (Anatomo-pathologiste) • Raymond Vande Weyer et Joël Thimpont (FMP) • Françoise Rey et Christian Boutin (Marseille et Corse) • Jean Bignon (Paris) • Izzet Baris (Ankara) • Chris Wagner et Allen Gibbs (Cardiff)

Recommend


More recommend